Merck KGaA secures second US CRISPR patent
09-04-2020
Merck KGaA secures CRISPR patents in Japan and Singapore
27-11-2019
Juriaan Wossink / shutterstock.com
Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Merck, CRISPR-Cas9, patents, portfolio, US, University of California, Broad Institute, USPTO, IP, gene-editing
